- Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study2016 | 2. lékařská fakulta
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | 2. lékařská fakulta
- PHF6 mutations in paediatric acute myeloid leukaemia2016 | 2. lékařská fakulta
- EAU guidelines vesikoureterální reflux u dětí2012 | 1. lékařská fakulta
- BCOR and BCORL1 mutations in pediatric acute myeloid leukemia2015 | 2. lékařská fakulta
- Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study2021 | 2. lékařská fakulta
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | 2. lékařská fakulta
- Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring2009 | 2. lékařská fakulta
- High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia2012 | 2. lékařská fakulta
- Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey2019 | 2. lékařská fakulta